Diagnostic performance of quantitative measures from [18F]FDG PET/CT, [18F]FEC PET/CT, and DW-MRI in the detection of lymph node metastases in endometrial and cervical cancer: data from the MAPPING study
European Journal of Nuclear Medicine and Molecular Imaging · 2026
DOI: 10.1007/s00259-025-07587-3 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift European Journal of Nuclear Medicine and Molecular Imaging, 2026. Verfasst von Ben G King und 19 weiteren Autor:innen. Beteiligte Einrichtung: The Institute of Genetics & Cancer, The University of Edinburgh, Edinburgh, UK. Hauptthemen laut MEDLINE: Fluorodeoxyglucose F18, Positron Emission Tomography Computed Tomography, Uterine Cervical Neoplasms, Endometrial Neoplasms. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cancer Research UK.
Abstract (Originalsprache)
Purpose
To evaluate the diagnostic performance of quantitative measures derived from [ 18 F]FDG PET/CT, [ 18 F]FEC PET/CT, and DW-MRI in the detection of lymph node metastases in endometrial and cervical cancer with comparison to standard visual PET analysis with histology as the reference standard.
Methods
Subanalysis of quantitative data from the prospective multicentre MAPPING study. Nodal and tumour SUV max from [ 18 F]FDG PET/CT and [ 18 F]FEC PET/CT and ADC mean from DW-MRI were documented. Nodal-to-tumour ratios (NTR) and SUV max -to-ADC mean ratio (STAR) were calculated. Optimal cut-offs of quantitative measures were compared to visual assessment on a regional basis using histopathology as the reference standard.
Results
Scans from 112 patients (36 cervical and 76 endometrial cancers; 340 nodal regions) were eligible for quantitative image analysis. Lower ADC mean on DW-MRI was observed in metastatic nodes for cervical cancer but not for endometrial cancer. Quantitative measures were significantly higher in malignant than benign nodal regions on [ 18 F]FDG PET/CT and [ 18 F]FEC PET/CT in endometrial cancer. SUV max cut-offs showed similar performance to visual assessment in the diagnosis of metastatic lymph nodes in endometrial cancer whilst ADC mean cut-offs showed significantly lower specificity than visual assessment. Interobserver agreement was excellent for SUV max measurements on both [ 18 F]FDG PET/CT and [ 18 F]FEC PET/CT, but poor for ADC mean on DW-MRI.
Conclusion
Quantitative measures from [ 18 F]FDG PET/CT, [ 18 F]FEC PET/CT, or DW-MRI did not outperform visual assessment in the detection of nodal metastases in endometrial cancer. Therefore, the implementation of these quantitative measures as standalone diagnostic tools in routine clinical practice is not recommended.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Institute of Genetics & Cancer, The University of Edinburgh, Edinburgh, UK.
- Department of Radiology, Imperial College Healthcare NHS Trust, London, UK.
- Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, UK.
- Cancer Research UK & UCL Cancer Trials Centre, London, UK.
- King's College London and Guy's and St Thomas' PET Centre, School of Biomedical Engineering and Imaging Sciences, King's College London, St. Thomas' Hospital, Westminster Bridge Road, London, UK.
- Department of Radiology, Royal Marsden Hospital NHS Foundation Trust, London, UK.
ORCID-Profile: Ben G King, Nishat Bharwani, William Wilson, Gary J R Cook, Aslam Sohaib, Victoria Warbey, Marc E Miquel, Dow-Mu Koh, Katja N De Paepe, Pierre Martin-Hirsch, Sadaf Ghaem-Maghami, Christina Fotopoulou, Helen Stringfellow, Sudha Sundar, Ranjit Manchanda, Anju Sahdev, Allan Hackshaw, Tara D Barwick, Andrea G Rockall
Förderung
- Cancer Research UK
Zitieren
APA
King, B. G., Bharwani, N., Wilson, W., Cook, G. J. R., Sohaib, A., Nobbenhuis, M., Warbey, V., Miquel, M. E., Koh, D. M., De Paepe, K. N., Martin-Hirsch, P., Ghaem-Maghami, S., Fotopoulou, C., Stringfellow, H., Sundar, S., Manchanda, R., Sahdev, A., Hackshaw, A., Barwick, T. D., & Rockall, A. G. (2026). Diagnostic performance of quantitative measures from [18F]FDG PET/CT, [18F]FEC PET/CT, and DW-MRI in the detection of lymph node metastases in endometrial and cervical cancer: data from the MAPPING study. European Journal of Nuclear Medicine and Molecular Imaging. https://doi.org/10.1007/s00259-025-07587-3
Vancouver
King BG, Bharwani N, Wilson W, Cook GJR, Sohaib A, Nobbenhuis M, et al. Diagnostic performance of quantitative measures from [18F]FDG PET/CT, [18F]FEC PET/CT, and DW-MRI in the detection of lymph node metastases in endometrial and cervical cancer: data from the MAPPING study. European Journal of Nuclear Medicine and Molecular Imaging. 2026. doi:10.1007/s00259-025-07587-3
BibTeX
@article{King2026,
author = {King, Ben G and Bharwani, Nishat and Wilson, William and Cook, Gary J R and Sohaib, Aslam and Nobbenhuis, Marielle and Warbey, Victoria and Miquel, Marc E and Koh, Dow-Mu and De Paepe, Katja N and Martin-Hirsch, Pierre and Ghaem-Maghami, Sadaf and Fotopoulou, Christina and Stringfellow, Helen and Sundar, Sudha and Manchanda, Ranjit and Sahdev, Anju and Hackshaw, Allan and Barwick, Tara D and Rockall, Andrea G},
title = {Diagnostic performance of quantitative measures from [18F]FDG PET/CT, [18F]FEC PET/CT, and DW-MRI in the detection of lymph node metastases in endometrial and cervical cancer: data from the MAPPING study},
journal = {European Journal of Nuclear Medicine and Molecular Imaging},
year = {2026},
doi = {10.1007/s00259-025-07587-3}
}
EUVIMED